Human monoclonal antibodies to IFN-α for the treatment of autoimmune diseases

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.16, Iss.2, 2006-02, pp. : 221-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4498-4507

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and / or High Dose Chemotherapy with Hematopoietic Stem Cell Support

Current Pharmaceutical Design, Vol. 9, Iss. 3, 2003-01 ,pp. : 279-288

Bentham Science Publishers

Access to resources Recommend Favorite

IFN-α carries mental-health risk

Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Monoclonal Antibodies in the Treatment of Multiple Sclerosis

Current Medicinal Chemistry, Vol. 16, Iss. 36, 2009-12 ,pp. : 4858-4868

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal antibodies for prophylaxis and therapy of infectious diseases

By Meulen Jan ter

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 4, 2007-11 ,pp. : 525-540

Informa Healthcare

Access to resources Recommend Favorite